Orthofix’s Growth Slows as It Struggles to Fill Leadership Roles

Orthofix reported 4Q19 orthopedic revenue of USD $121.5 million, +0.3% vs. 4Q18, with full-year 2019 revenue of $460 million, +1.5% vs. 2018. The company remains negatively impacted by its structural organization and vacancies in leadership positions.

Orthofix’s largest business segment, bone growth therapies, lost two key distributors...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us